Purinergic signalling in inflammation of the central nervous system

Trends in Neurosciences

Volumn 32, Issue 2, 2009, Pages 79-87

  Di Virgilio, Francesco ^a   Ceruti, Stefania ^b   Bramanti, Placido ^c   Abbracchio, Maria P ^b  

^a Interdisciplinary Center for the Study of Inflammation   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; PURINERGIC P2X RECEPTOR; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X3 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; PURINERGIC RECEPTOR;

ASTROCYTE; ASTROCYTOSIS; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; IMMUNITY; INFLAMMATION; LEUKOCYTE; LYMPHOCYTE; MICROGLIA; NERVE CELL LESION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; AUTOIMMUNITY; ENCEPHALITIS; GLIOSIS; HUMANS; INFLAMMATION MEDIATORS; MICROGLIA; NUCLEOTIDES; PURINES; RECEPTORS, PURINERGIC; SIGNAL TRANSDUCTION;

EID: 58949094359     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2008.11.003     Document Type: Review

References (86)

1. Barton G.M. A calculated response: control of inflammation by the innate immune system. J. Clin. Invest. 118 (2008) 413-420
2. Medzhitov R. Origin and physiological roles of inflammation. Nature 454 (2008) 428-435
3. la Sala A., et al. Alerting and tuning the immune response by extracellular nucleotides. J. Leukoc. Biol. 73 (2003) 339-343
4. Khakh B.S., and North R.A. P2X receptors as cell-surface ATP sensors in health and disease. Nature 442 (2006) 527-532
5. Dwyer K.M., et al. CD39 and control of cellular immune responses. Purinergic Signal. 3 (2007) 171-180
6. Abbracchio, M.P. et al. Purinergic signalling in the nervous system: an overview. Trends Neurosci. DOI:10.1016/j.tins.2008.10.001 (www.sciencedirect.com)
7. Abbracchio M.P., and Ceruti S. P1 receptors and cytokine secretion. Purinergic Signal. 3 (2007) 13-25
8. Yegutkin G.G. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim. Biophys. Acta 1783 (2008) 673-694
9. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 775-787
10. Bours M.J., et al. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol. Ther. 112 (2006) 358-404
11. Dahlquist R., and Diamant B. Further observations on ATP-induced histamine release from rat mast cells. Acta Pharmacol. Toxicol. (Copenh.) 28 (1970) 43
12. Cockcroft S., and Gomperts B.D. The ATP4- receptor of rat mast cells. Biochem. J. 188 (1980) 789-798
13. Di Virgilio F., et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97 (2001) 587-600
14. Perregaux D., and Gabel C.A. Interleukin-1β maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem 269 (1994) 15195-15203
15. Ferrari D., et al. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 156 (1996) 1531-1539
16. 7 and the inflammasome. Trends Pharmacol. Sci. 28 (2007) 465-472
17. Idzko M., et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13 (2007) 913-919
18. Pellegatti P., et al. Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 3 (2008) e2599
19. Abbracchio M.P., and Verderio C. Pathophysiological roles of P2 receptors in glial cells. Novartis Found. Symp. 276 (2006) 91-103
20. Murgia M., et al. Oxidized ATP. An irreversible inhibitor of the macrophage purinergic P2Z receptor. J. Biol. Chem 268 (1993) 8199-8203
21. Ferrari D., et al. Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages. J. Immunol. 159 (1997) 1451-1458
22. Chen Y., et al. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314 (2006) 1792-1795
23. Grbic D.M., et al. Intestinal inflammation increases the expression of the P2Y6 receptor on epithelial cells and the release of CXC chemokine ligand 8 by UDP. J. Immunol. 180 (2008) 2659-2668
24. Bar I., et al. Knock-out mice reveal a role for P2Y6 receptor in macrophages, endothelial cells and vascular smooth muscle cells. Mol. Pharmacol. 74 (2008) 777-784
25. la Sala A., et al. Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses. J. Immunol. 166 (2001) 1611-1617
26. Wilkin F., et al. Extracellular adenine nucleotides modulate cytokine production by human monocyte-derived dendritic cells: dual effect on IL-12 and stimulation of IL-10. Eur. J. Immunol. 32 (2002) 2409-2417
27. Schnurr M., et al. ATP gradients inhibit the migratory capacity of specific human dendritic cell types: implications for P2Y11 receptor signaling. Blood 102 (2003) 613-620
28. Deaglio S., et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204 (2007) 1257-1265
29. Borsellino G., et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 110 (2007) 1225-1232
30. Zimmermann H. Ectonucleotidases in the nervous system. Novartis Found. Symp. 276 (2006) 113-128
31. Hanisch U.K., and Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10 (2007) 1387-1394
32. Uwe-Karsten, H. et al. (eds), (2002) Glia 40, 131-269
33. Norenberg W., et al. Characterization and possible function of adenosine 5′-triphosphate receptors in activated rat microglia. Br. J. Pharmacol. 111 (1994) 942-950
34. Ferrari D., et al. Purinergic modulation of interleukin-1β release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med. 185 (1997) 579-582
35. Ferrari D., et al. Extracellular ATP activates transcription factor NF-κB through the P2Z purinoreceptor by selectively targeting NF-κB p65. J. Cell Biol. 139 (1997) 1635-1643
36. 2+-dependent plasminogen release from cultured microglia. Br. J. Pharmacol. 123 (1998) 1304-1310
37. Parvathenani L.K., et al. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 278 (2003) 13309-13317
38. Bianco F., et al. A role for P2X7 in microglial proliferation. J. Neurochem. 99 (2006) 745-758
39. Tsuda M., et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424 (2003) 778-783
40. Koizumi S., et al. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 446 (2007) 1091-1095
41. Kobayashi K., et al. P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J. Neurosci. 28 (2008) 2892-2902
42. Tozaki-Saitoh H., et al. P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J. Neurosci. 28 (2008) 4949-4956
43. Haynes S.E., et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9 (2006) 1512-1519
44. i/o-coupled P2Y receptors. J. Neurosci. 21 (2001) 1975-1982
45. Ohsawa K., et al. Involvement of P2X4 and P2Y12 receptors in ATP-induced microglial chemotaxis. Glia 55 (2007) 604-616
46. Inoue K. Purinergic systems in microglia. Cell. Mol. Life Sci. 65 (2008) 3074-3080
47. Abbracchio M.P., and Ceruti S. Roles of P2 receptors in glial cells: focus on astrocytes. Purinergic Signal. 2 (2006) 595-604
48. Cotrina M.L., et al. Connexins regulate calcium signaling by controlling ATP release. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 15735-15740
49. Fields R.D., and Burnstock G. Purinergic signalling in neuron-glia interactions. Nat. Rev. Neurosci. 7 (2006) 423-436
50. Marchetti B., and Abbracchio M.P. To be or not to be (inflamed)-is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?. Trends Pharmacol. Sci. 26 (2005) 517-525
51. Neary J.T., et al. P2 receptor signalling, proliferation of astrocytes, and expression of molecules involved in cell-cell interactions. Novartis Found. Symp. 276 (2006) 131-143
52. Franke H., et al. P2 receptors and neuronal injury. Pflugers Arch. 452 (2006) 622-644
53. Zipp F., and Aktas O. The brain as a target of inflammation: common pathways link inflammatory and neurodegenerative diseases. Trends Neurosci. 29 (2006) 518-527
54. Fabry Z., et al. Sensing the microenvironment of the central nervous system: immune cells in the central nervous system and their pharmacological manipulation. Curr. Opin. Pharmacol. 8 (2008) 496-507
55. Swennen E.L., et al. Immunoregulatory effects of adenosine 5′-triphosphate on cytokine release from stimulated whole blood. Eur. J. Immunol. 35 (2005) 852-858
56. Solini A., et al. Purinergic modulation of mesangial extracellular matrix production: role in diabetic and other glomerular diseases. Kidney Int. 67 (2005) 875-885
57. H17 cell differentiation. Nature 455 (2008) 808-812
58. Siffrin V., et al. New insights into adaptive immunity in chronic neuroinflammation. Adv. Immunol. 96 (2007) 1-40
59. Takenouchi T., et al. Prion infection correlates with hypersensitivity of P2X7 nucleotide receptor in a mouse microglial cell line. FEBS Lett. 581 (2007) 3019-3026
60. Witting A., et al. Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 6362-6367
61. Sharp A.J., et al. P2x7 deficiency suppresses development of experimental autoimmune encephalomyelitis. J. Neuroinflammation 5 (2008) 33
62. Matute C., et al. P2X7 receptor blockade prevents ATP excitotoxicity in oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J. Neurosci. 27 (2007) 9525-9533
63. Yiangou Y., et al. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol 6 (2006) 12
64. Chessell I.P., et al. Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain 114 (2005) 386-396
65. Fulgenzi A., et al. Periodate oxidized ATP (oATP) reduces hyperalgesia in mice: involvement of P2X7 receptors and implications for therapy. Int. J. Immunopathol. Pharmacol. 21 (2008) 61-71
66. Avignone E., et al. Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling. J. Neurosci. 28 (2008) 9133-9144
67. Harvey M., et al. Gene interactions in depression: pathways out of darkness. Trends Genet. 23 (2007) 547-556
68. Lucae S., et al. P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum. Mol. Genet. 15 (2006) 2438-2445
69. Barden N., et al. Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. Am. J. Med. Genet. B. Neuropsychiatr. Genet 141B (2006) 374-382
70. Casanovas A., et al. Strong P2X4 purinergic receptor-like immunoreactivity is selectively associated with degenerating neurons in transgenic rodent models of amyotrophic lateral sclerosis. J. Comp. Neurol. 506 (2008) 75-92
71. Arthur D.B., et al. Inhibition of apoptosis by P2Y2 receptor activation: novel pathways for neuronal survival. J. Neurosci. 26 (2006) 3798-3804
72. Arthur D.B., et al. P2Y2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 19138-19143
73. Zimmermann H. Nucleotide signaling in nervous system development. Pflugers Arch. 452 (2006) 573-588
74. Wang X., et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat. Med. 10 (2004) 821-827
75. Davalos D., et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8 (2005) 752-758
76. Ferrari D., et al. The P2X7 receptor: a key player in IL-1 processing and release. J. Immunol. 176 (2006) 3877-3883
77. Ciana P., et al. The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor. EMBO J. 25 (2006) 4615-4627
78. Burnstock G. Purinergic signalling and disorders of the central nervous system. Nat. Rev. Drug Discov. 7 (2008) 575-590
79. Schwarzschild M.A., et al. Targeting adenosine A2A receptors in Parkinson's disease. Trends Neurosci. 29 (2006) 647-654
80. Popoli P., et al. Functions, dysfunctions and possible therapeutic relevance of adenosine A2A receptors in Huntington's disease. Prog. Neurobiol. 81 (2007) 331-348
81. Ekdahl, C.T. et al. Brain inflammation and adult neurogenesis: the dual role of microglia. Neuroscience DOI:10.1016/j.neuroscience.2008.06.052. (www.sciencedirect.com)
82. Chen Y., et al. A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors. J. Leukoc. Biol. 76 (2004) 245-253
83. Mishra S.K., et al. Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation. Development 133 (2006) 675-684
84. Lin J.H., et al. Purinergic signaling regulates neural progenitor cell expansion and neurogenesis. Dev. Biol. 302 (2007) 356-366
85. Maisel M., et al. Transcription profiling of adult and fetal human neuroprogenitors identifies divergent paths to maintain the neuroprogenitor cell state. Stem Cells 25 (2007) 1231-1240
86. Simard A.R., and Rivest S. Role of inflammation in the neurobiology of stem cells. Neuroreport 15 (2004) 2305-2310